Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Trading 02-25 10:22:53 EST

926.28

+0.05

+0.01%

High930.84	Low921.64	Vol98.74M
Open926.23	D1 Closing926.23	Amplitude0.99%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O3.02B	T/O Rate--	Tradable Shares0.00
P/B5.489733	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":926.27637,"timestamp":1772032973410,"preClose":926.22595,"halted":0,"volume":98738983,"delay":0,"changeRate":0.000054,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":0.050415,"latestTime":"02-25 10:22:53 EST","open":926.2259,"high":930.8391,"low":921.6354,"amount":3016256392.416115,"amplitude":0.009937,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.489733,"peRate":26.855175,"turnoverRate":0.002236,"increases":118,"decrements":67,"flats":6,"marketCap":3647099219313.25,"floatMarketCap":3496430381585.125},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2614877051","title":"BRAIN Biotech posts Q1 net loss of EUR 2.9 million, revenue down 9% to EUR 11.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614877051","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614877051?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:30","pubTimestamp":1772001047,"startTime":"0","endTime":"0","summary":"BRAIN Biotech reported Q1 FY 2025/26 revenue of EUR 11.9 million, down 9.0%, with total operating performance of EUR 13.0 million. Adjusted EBITDA was EUR 0.3 million, while EBITDA was EUR -0.3 million and EBIT was EUR -1.5 million. Net loss for the period was EUR 2.9 million, with EPS  of EUR -0.13. In BRAINBiocatalysts, Q1 revenue was EUR 10.0 million  and adjusted EBITDA was EUR 0.5 million, with the company citing low sales momentum in baking enzymes and production interruptions tied to the relocation of production facilities to a new joint site in the Netherlands. BRAINBioIncubator Q1 revenue was EUR 1.9 million, supported by a EUR 1.0 million milestone payment related to the deucrictibant project; the company also noted that license and monetization agreements with Pharvaris and Royalty Pharma have generated EUR 3.3 million in milestone payments so far in FY 2025/26, including EUR 2.3 million received as cash inflow in Q1. Cash and cash equivalents were EUR 5.1 million at 31 Dece","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL5DmRdQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","PHVS","BK4007"],"gpt_icon":0},{"id":"2614772768","title":"Bristol-Myers Squibb Co : Berenberg Raises Target Price to $60 From $57","url":"https://stock-news.laohu8.com/highlight/detail?id=2614772768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614772768?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:52","pubTimestamp":1771998765,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL0GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","LU1261432733.SGD","LU2125154935.USD","LU1585245621.USD","LU0237698245.USD","LU2360032135.SGD","LU0114720955.EUR","LU0306807586.USD","LU1670710588.SGD","BK4532","LU1883839398.USD","LU1571399168.USD","IE0002141913.USD","IE00BSNM7G36.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU1093756325.SGD","BK4588","BK4559","BMY","LU1868836591.USD","LU0267386448.USD","LU0096364046.USD","LU0456855351.SGD","LU2125154778.USD","LU0225771236.USD","IE00BFXG1179.USD","LU1670711040.USD","LU1989771016.USD","LU1032466523.USD","LU1868837300.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU0061475181.USD","BK4007","LU2242652126.USD","LU1291159041.SGD","LU1868836914.USD","LU1074936037.SGD","LU0321505439.SGD","LU0225284248.USD","LU1323610961.USD","LU1718418525.SGD","LU0306806265.USD","LU1430594728.SGD","LU0321505868.SGD","LU2242646821.SGD","BK4585","LU0882574055.USD"],"gpt_icon":0},{"id":"2614447772","title":"Bioage Labs Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2614447772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614447772?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:45","pubTimestamp":1771998354,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL0BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2614779809","title":"Sembcorp Industries' H2 Profit Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614779809","media":"MT Newswires","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614779809?lang=en_us&edition=fundamental","pubTime":"2026-02-25 11:41","pubTimestamp":1771990910,"startTime":"0","endTime":"0","summary":"Sembcorp Industries'  profit attributable to owners declined by 5% in the second half of 2025 to SG$448 million from SG$473 million a year earlier, according to a Wednesday filing with the Singapore Exchange.Earnings per share dropped to SG$0.2496 from SG$0.2663 in the year-ago period. Analysts from Visible Alpha had projected EPS of SG$0.25 for the period.Turnover fell 11% year over year to SG$2.86 billion from SG$3.21 billion.The energy and urban development company declared a final dividend of SG$0.16 per share, down from SG$0.17 per share a year earlier. It will be paid on May 15.Total dividends for 2025 amounted to SG$0.25 per share, up from SG$0.23 per share in 2024.Shares of the company were down over 2% in Wednesday trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999000343.SGD","SG9999016042.SGD","SGXZ27511609.SGD","SG9999001226.SGD","SG9999008742.SGD","SG9999004360.SGD","LU2238330802.EUR","IE00B12V2V27.USD","BK6113","SG9999001135.SGD","IE00BYQNZ168.SGD","SGXZ43160589.SGD","BK6500","SGXZ24219693.SGD","SG9999011746.SGD","IE00BYTNYN87.SGD","SG9999000475.SGD","SG9999003826.SGD","SG9999006266.SGD","SG9999014492.USD","U96.SI","SG9999014484.SGD","BK4007"],"gpt_icon":1},{"id":"1199514190","title":"Pfizer's Oral Cancer Medication Braftovi Receives FDA Approval for Colorectal Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1199514190","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199514190?lang=en_us&edition=fundamental","pubTime":"2026-02-25 11:18","pubTimestamp":1771989530,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration (FDA) has granted approval for the first-line combination therapy of the oral anticancer drug Braftovi, developed by Pfizer in collaboration with Japan's Ono...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999001176.SGD","BK4588","SG9999002232.USD","IE00B19Z3581.USD","LU0234572021.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683264.USD","BK4533","LU0306807586.USD","SG9999013999.USD","BK4568","SG9999003800.SGD","LU0058720904.USD","LU0456855351.SGD","SG9999001176.USD","LU1883839398.USD","PFE","LU0306806265.USD","BK4585","LU1894683348.USD","SG9999002224.SGD","LU0321505439.SGD","BK4534","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0122379950.USD","IE00BLSP4452.SGD","BK4550","LU1057294990.SGD","LU0225284248.USD","LU0985481810.HKD","LU1066053197.SGD","BK4007","IE00BBT3K403.USD","BK4592","LU0170899867.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","BK4581","LU0225771236.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2614775517","title":"Investors File Securities Fraud Class Action Against Corcept Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2614775517","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614775517?lang=en_us&edition=fundamental","pubTime":"2026-02-25 10:49","pubTimestamp":1771987744,"startTime":"0","endTime":"0","summary":"A securities fraud class action lawsuit has been filed against Corcept Therapeutics Incorporated in the U.S. District Court for the Northern District of California on behalf of investors who acquired shares between Oct. 31, 2024 and Dec. 30, 2025. The suit alleges the company and certain executives failed to disclose material information about the likelihood of FDA approval for relacorilant, after the FDA issued a Complete Response Letter seeking additional evidence of effectiveness. Corcept shares fell 50.4% on Dec. 31, 2025 following the disclosure, and investors have until April 21, 2026 to seek appointment as lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL7MYPr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4532","LU2095319765.USD","SG9999014013.SGD","SG9999014005.SGD","LU0566484027.USD","BK4007","SG9999014021.USD","BK4112","LU1559883803.SGD","BK4585","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","CORT","IE00B64PRP62.GBP","IE00BKPKM429.USD","NDAQ","BK4588"],"gpt_icon":0},{"id":"2614773944","title":"Big Insider Moves Shake Up Ocular Therapeutix Leadership’s Bet on the Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2614773944","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614773944?lang=en_us&edition=fundamental","pubTime":"2026-02-25 10:09","pubTimestamp":1771985380,"startTime":"0","endTime":"0","summary":"New insider activity at Ocular Therapeutix ( ($OCUL) ) has taken place on February 24, 2026. Insider trading activity at Ocular Therapeutix has sho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/big-insider-moves-shake-up-ocular-therapeutix-leaderships-bet-on-the-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/big-insider-moves-shake-up-ocular-therapeutix-leaderships-bet-on-the-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2614720826","title":"How JNJ, TEM, and LLY Used AI to Redefine Healthcare Compounding","url":"https://stock-news.laohu8.com/highlight/detail?id=2614720826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614720826?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:06","pubTimestamp":1771981560,"startTime":"0","endTime":"0","summary":"Artificial intelligence (AI) is no longer a futuristic concept in healthcare — it is rapidly becoming a core engine of innovation across diagnostic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/how-jnj-tem-and-lly-used-ai-to-redefine-healthcare-compounding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/how-jnj-tem-and-lly-used-ai-to-redefine-healthcare-compounding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","LU1059921491.USD","IE00BK4W5M84.HKD","BK4533","BK4588","LU1914381329.SGD","LU2505996509.AUD","LU0795875086.SGD","LU2552382132.HKD","LU2265009873.SGD","LU0109391861.USD","LU2360106947.USD","LU1066051225.USD","LU2552382215.SGD","IE00BDGV0183.EUR","LU2271345857.HKD","IE00BBT3K403.USD","LU0029874061.USD","LU1804176565.USD","LU0471298777.SGD","IE00BLSP4239.USD","LU0471298694.HKD","LU1917777945.USD","LU2430703178.SGD","IE00B3PB1722.GBP","LU1032955483.USD","IE0002141913.USD","LU2213496289.HKD","LU0289739699.SGD","LU0689472784.USD","SG9999014880.SGD","LU1035775433.USD","IE00B19Z3581.USD","LU2168564222.USD","IE00BVYPNW00.USD","LU0094547139.USD","IE00BFXG1179.USD","LU0114720955.EUR","SG9999017495.SGD","BK4611","LU2491050154.USD","LU2756315664.SGD","IE0034235303.USD","LU2505996681.GBP","IE00BFSS7M15.SGD","IE00BJJMRY28.SGD","LU0708995401.HKD","IE00BZ1G4Q59.USD","LU0345770308.USD","LU0061475181.USD","BK4023","LU0345769128.USD","IE00BKVL7J92.USD","LU0689626769.HKD","BK4585","LU1868837300.USD","LU1868836914.USD","LU0889565916.HKD","LU0109394709.USD","IE00B7SZLL34.SGD","IE0005OL40V9.USD","LU0912757837.SGD","LU2089283258.USD","LU2324357040.USD","LABU","LU1868837136.USD","LU2089984988.USD","LU1267930813.SGD","LU2750360997.AUD","SG9999014914.USD","BK4137","LU2592432038.USD","LU2264538146.SGD","LU1244550577.SGD","LU1989771016.USD","LU0203202063.USD","LU1861559042.SGD","LU1064131342.USD","LU0096364046.USD","SGXZ57979304.SGD","LU1069344957.HKD","LU2023251221.USD","IE00B775H168.HKD","LU2106854487.HKD","BK4592","LU0345769631.USD","LU1861558580.USD","LU0266013472.USD","LU2211815571.USD","LU1718418525.SGD","LU1732799900.SGD","LU0432979614.USD","IE00BVYPNV92.GBP","IE00B1BXHZ80.USD","LU0158827948.USD","LU2129689514.USD","LU2750360641.GBP","LU2357305700.SGD","LU0672654240.SGD","LU1551013425.SGD","LU0820561909.HKD","LU2237443382.USD","TEMT","LU1127390331.HKD","IE00B4R5TH58.HKD","LU1366192091.USD","LU0316494557.USD","SG9999018865.SGD","SG9999014898.SGD","LU0006306889.USD","IE00B3T34201.USD","LU0882574055.USD","BK4599","LU1162221912.USD","LU0323591593.USD","LU0320765646.SGD","LU1506573853.SGD","LU1061106388.HKD","LU1032466523.USD","IE00BN8TJ469.HKD","SG9999015945.SGD","IE00B4JS1V06.HKD","SG9999001440.SGD","LU2129689605.HKD","LU0256863902.USD","IE00BK4W5L77.USD","ELIS","SG9999013999.USD","IE0004445015.USD","ELIL","SGXZ31699556.SGD","IE0004445239.USD","IE00BGHQF631.EUR","LU1551013342.USD","LU1778281490.HKD","LU0345770993.USD","LU2468319806.SGD","LU0820561818.USD","LU2023250504.SGD","LU2430703251.USD","LU0198837287.USD","LU0354030438.USD","LU1291159041.SGD","LU1720051017.SGD","LU1323610961.USD","SG9999001176.USD","LU1196500208.SGD","LU2347655156.SGD","XBI","BK4007","LU2237443622.USD","LU1720051108.HKD","LU0234572021.USD","LU2028103732.USD","LU0203345920.USD","SGXZ81514606.USD","LU1674673691.USD","IE00BWXC8680.SGD","LU2168563687.JPY","LU2087625088.SGD","LU1929549753.HKD","LU2168564495.EUR","LU2456880835.USD","LU0234570918.USD","LU0889566641.SGD","LU0320765992.SGD","LU0882574139.USD","LU0128526141.USD","LU1623119135.USD","LU1066053197.SGD","LU0353189680.USD","LU0070217475.USD","LU0823434740.USD","JNJ","LU0786609619.USD","IE00B42XCP33.USD","LU0256863811.USD","LU2756315318.SGD","LU1244550494.USD","LU1093756168.USD","LU2111349929.HKD","SG9999018857.SGD","LU2112291526.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","BK4121","LU1629891620.HKD","LU1145028129.USD","LU0964807845.USD","LU2129689431.USD","LU2552382058.USD","IE00BLSP4452.SGD","BK4504","LU2237443978.SGD","LU2471134879.HKD","LU2430703095.HKD","LU1868836591.USD","LU0122379950.USD","BK4528","LU1221951129.SGD","BK4559","LU2168564065.EUR","LU1868836757.USD","LU1496350502.SGD","LU0124676726.USD","LU0640476718.USD","TEM","LU0820562030.AUD","BK4587","LU2237443549.SGD","IE00B19Z3B42.SGD","LU1074936037.SGD","BK4534","LU0985320562.USD","LU1244550221.USD","LU2602419157.SGD","LU1974910355.USD","IE0009355771.USD","LU1267930730.SGD","IE000M9KFDE8.USD","LU1261432733.SGD","LU0792757196.USD","LU0079474960.USD","LU1894683348.USD","LU1814569148.SGD","LU2063271972.USD","SG9999002224.SGD","AIYY","LU0943347566.SGD","LU2746668461.USD","LU2471134796.USD","IE0001KFT4U8.USD","LU0466842654.USD","LU0210536198.USD","IE00BFSS8Q28.SGD","LLYX","LU0098860793.USD","LU1232071149.USD","IE00BJJMRX11.SGD","LU2237443465.HKD","LU0683600562.USD","BK4516","LU1674673428.USD","LU0787776722.HKD","LU0823416689.USD","LU1066051498.USD","LU2133065610.SGD","LU0353189763.USD","LU1712237335.SGD","LU0106261372.USD","LU1430594728.SGD","LLII","LU0225283273.USD","LU2089284900.SGD","LU2471134523.USD","LU0354030511.USD","BK4551","LU2491050071.SGD","SGXZ99366536.SGD","IE00BKPKM429.USD","SG9999001176.SGD","LU0823434583.USD","LU1894683264.USD","LU1548497426.USD","LU1585245621.USD","LLY","LU2361044865.SGD","LU2168564149.EUR","SG9999015986.USD","LU1983299246.USD","LU0417517546.SGD","LU2462157665.USD","LU1935042991.SGD","LU0456855351.SGD","LU0320765059.SGD","LU0385154629.USD","IE00BKDWB100.SGD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU1221951046.USD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU2461242641.AUD","LU0158827781.USD","LU2023250330.USD","LU2896262040.SGD","LU0795875169.SGD","SG9999015978.USD","LU1057294990.SGD","BK4568","LU1732800096.USD","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","BK4581","BK4532","SG9999002232.USD","IE00BJLML261.HKD","LU2237443895.HKD","LU0238689110.USD","LU0058720904.USD","BK4613","LU2417539215.USD","BK4543","SGXZ51526630.SGD","LU1093756325.SGD","LU2471134952.CNY","SG9999014906.USD","LU0203201768.USD","LU2237438978.USD","LU2236285917.USD","LU1280957306.USD","LLYZ","LU1988902786.USD","LU2361045086.USD","LU1066051811.HKD","LU0097036916.USD","IE00B1XK9C88.USD","SG9999015952.SGD","LU2108987350.USD","IE0002270589.USD","LU1023059063.AUD","LU2746668974.SGD","LU2491049909.HKD","IE00BN29S564.USD"],"gpt_icon":0},{"id":"2614727304","title":"Amplia Therapeutics Appoints CFO; Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614727304","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614727304?lang=en_us&edition=fundamental","pubTime":"2026-02-25 08:57","pubTimestamp":1771981024,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics (ASX:ATX) has appointed Hamish George as chief financial officer, succeeding Tim Luscombe, effective Wednesday, according to a same-day filing with the Australian bourse.The company's shares fell around 8% in recent Wednesday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","BK4007","BK7067","ATX.AU","LENZ"],"gpt_icon":0},{"id":"2614722854","title":"Chimeric Therapeutics Revises Terms and Timing of Convertible Note Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2614722854","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614722854?lang=en_us&edition=fundamental","pubTime":"2026-02-25 08:18","pubTimestamp":1771978684,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an announcement. Chimeric Therapeutics has updated the terms of its proposed placement involv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-revises-terms-and-timing-of-convertible-note-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-revises-terms-and-timing-of-convertible-note-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2614724509","title":"Chimeric Therapeutics Secures Funding to Complete Phase 1 CAR‑T Trial and Launches Strategic Reset","url":"https://stock-news.laohu8.com/highlight/detail?id=2614724509","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614724509?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:56","pubTimestamp":1771977373,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has issued an update. Chimeric Therapeutics has provided an update on its previously announced A$8.4 milli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-secures-funding-to-complete-phase-1-car‑t-trial-and-launches-strategic-reset?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-secures-funding-to-complete-phase-1-car‑t-trial-and-launches-strategic-reset?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAR","BK4539","BK4230","BK4007","BK4139","BK4022","LENZ"],"gpt_icon":0},{"id":"2614724653","title":"Elanco CEO: We’ve transitioned into a sustainable growth company","url":"https://stock-news.laohu8.com/highlight/detail?id=2614724653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614724653?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:50","pubTimestamp":1771977018,"startTime":"0","endTime":"0","summary":"In an interview on CNBC’s Mad Money, Jeff Simmons said Elanco (ELAN) is focused on growth, innovation and cash. The company has the best pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elanco-ceo-weve-transitioned-into-a-sustainable-growth-company-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elanco-ceo-weve-transitioned-into-a-sustainable-growth-company-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1941712348.USD","LU1941712264.USD","ELAN","BK4561","BK4007"],"gpt_icon":0},{"id":"2614721518","title":"Sembcorp appoints Dinesh Khanna as alternate director to Uwe Krueger","url":"https://stock-news.laohu8.com/highlight/detail?id=2614721518","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614721518?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:18","pubTimestamp":1771975135,"startTime":"0","endTime":"0","summary":"Sembcorp Industries has appointed Dinesh Khanna as alternate director to Prof Uwe Krueger, effective February 25, 2026. Khanna is Joint Head of the Portfolio Development Group at Temasek International and previously spent over two decades at Boston Consulting Group.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SCI - SembCorp Industries Ltd. published the original content used to generate this news brief via Singapore Exchange Limited   on February 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL514cqG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0188438112.USD","SG9999014492.USD","SGXZ58947870.SGD","SG9999006266.SGD","BK4007","LU0831103253.SGD","SG9999000343.SGD","SGXZ24219693.SGD","SGXZ43160589.SGD","SG9999013478.USD","SG9999003826.SGD","LU2242646235.USD","IE00B12V2V27.USD","LU1119993845.HKD","SG9999016042.SGD","LU1839390173.USD","SG9999001846.SGD","U96.SI","SG9999014484.SGD","LU0877626530.USD","LU2242652126.USD","IE00BYQNZ168.SGD","SG9999008742.SGD","SG9999001226.SGD","LU2238330802.EUR","LU1920062954.HKD","LU0898667661.SGD","BK6113","SG9999004360.SGD","SG9999011746.SGD","SG9999013486.USD","BK6033","SG9999013460.SGD","LU0532188223.SGD","LU2401740654.USD","IE00BYTNYN87.SGD","LU0205439572.USD","BK6500","SG9999001135.SGD","IE00BKZH1Z71.USD","SGXZ27511609.SGD","LU0192582467.USD","LU0441851309.USD","BK6516","BK6523","LU2242646821.SGD","LU0326948709.USD","SG9999000475.SGD","LU1920063259.USD"],"gpt_icon":1},{"id":"2614519721","title":"Sembcorp Industries Ltd Appointment of Alternate Director to Prof Uwe Krueger","url":"https://stock-news.laohu8.com/highlight/detail?id=2614519721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614519721?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:18","pubTimestamp":1771975124,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUE4CVLK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["U96.SI","BK4007","IE00BYTNYN87.SGD","SG9999006266.SGD","SG9999000343.SGD","IE00BYQNZ168.SGD","SG9999003826.SGD","SG9999001226.SGD","SGXZ24219693.SGD","SG9999000475.SGD","LU2238330802.EUR","SG9999001135.SGD","BK6113","SGXZ43160589.SGD","BK6500","SG9999008742.SGD","SG9999004360.SGD","SG9999016042.SGD","IE00B12V2V27.USD","SG9999014492.USD","SG9999011746.SGD","SG9999014484.SGD","SGXZ27511609.SGD"],"gpt_icon":0},{"id":"2614721567","title":"Singapore's Sembcorp Industries posts slight drop in annual profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2614721567","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614721567?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:16","pubTimestamp":1771975009,"startTime":"0","endTime":"0","summary":"Singapore's Sembcorp Industries posts slight drop in annual profitFeb 25 (Reuters) - Singapore's Sembcorp Industries SCIL.SI posted a marginal drop in annual profit on Wednesday, as strong performance","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK1X7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2238330802.EUR","BK4007","SG9999000475.SGD","SG9999000343.SGD","IE00BYQNZ168.SGD","SG9999008742.SGD","SGXZ27511609.SGD","SG9999003826.SGD","SG9999006266.SGD","BK6500","IE00B12V2V27.USD","U96.SI","SG9999001135.SGD","IE00BYTNYN87.SGD","SGXZ43160589.SGD","SG9999014484.SGD","SG9999011746.SGD","SG9999001226.SGD","SG9999014492.USD","SGXZ24219693.SGD","BK6113","SG9999004360.SGD","SG9999016042.SGD"],"gpt_icon":1},{"id":"2614721344","title":"Richard L. Lindstrom MD Acquires Ocular Therapeutix Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614721344","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614721344?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:13","pubTimestamp":1771974813,"startTime":"0","endTime":"0","summary":"Richard L. Lindstrom, M.D., a beneficial owner of Ocular Therapeutix Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL7v7xTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Richard L. Lindstrom MD Acquires Ocular Therapeutix Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2614052729","title":"Sembcorp Industries Ltd FY Turnover SGD 5,799 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614052729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614052729?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:04","pubTimestamp":1771974256,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLXAFB1F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999004360.SGD","SG9999000343.SGD","IE00B12V2V27.USD","SG9999006266.SGD","SG9999016042.SGD","BK6113","SGXZ27511609.SGD","SG9999014484.SGD","SG9999000475.SGD","SG9999001226.SGD","U96.SI","LU2238330802.EUR","SG9999014492.USD","SG9999003826.SGD","IE00BYQNZ168.SGD","SGXZ24219693.SGD","BK6500","BK4007","IE00BYTNYN87.SGD","SG9999008742.SGD","SG9999001135.SGD","SG9999011746.SGD","SGXZ43160589.SGD"],"gpt_icon":0},{"id":"2614729715","title":"Nektar Therapeutics to Present at TD Cowen Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614729715","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614729715?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:00","pubTimestamp":1771974018,"startTime":"0","endTime":"0","summary":"Nektar Therapeutics to Present at TD Cowen Annual Health Care Conference               Nektar Therapeutics said its management will participate in the TD Cowen 46th Annual Health Care Conference in Bo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL87bPNl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTR","BK4007","EVT.AU","BK7035"],"gpt_icon":0},{"id":"2614729160","title":"BRIEF-Hoth Therapeutics Accelerates HT-001 Trial Enrollment With New Clinical Site As Patient Demand Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2614729160","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614729160?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:51","pubTimestamp":1771973506,"startTime":"0","endTime":"0","summary":"BRIEF-Hoth Therapeutics Accelerates HT-001 Trial Enrollment With New Clinical Site As Patient Demand IncreasesFeb 24 (Reuters) - Hoth Therapeutics Inc HOTH.O:HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA3GTTHQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HOTH"],"gpt_icon":0},{"id":"2614729661","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2614729661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614729661?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:43","pubTimestamp":1771972980,"startTime":"0","endTime":"0","summary":"Blue Owl Capital             OWL    65,787,061     10.73     0.29      2.78. Hims & Hers Health          HIMS    63,794,531     15.46    -0.05     -0.32. Bank of America              BAC    53,050,945     50.41    -0.66     -1.29. Nu Holdings Cl A              NU    49,687,066     16.53     0.34      2.10. Novo Nordisk ADR             NVO    43,800,414     38.59    -1.04     -2.62. Itau Unibanco ADR           ITUB    29,765,557      9.33     0.16      1.74. Petroleo Brasileiro ADR      PBR    26,646,509     16.54     0.40      2.48","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4553","NYSE","LU0683600562.USD","LU1093756168.USD","BK4547","SGXZ57979304.SGD","LU1883839398.USD","LU0128525689.USD","SG9999001176.SGD","LU2129689605.HKD","LU1861559042.SGD","LU0320765489.SGD","LU0985481810.HKD","LU1506573853.SGD","PATH","IE00BBT3K403.USD","IE0034235188.USD","LU1035773651.USD","LU1280957306.USD","LU2133065610.SGD","IE00B19Z3581.USD","BK4592","LU1162221912.USD","LU1880398471.USD","LU1861558580.USD","BK4604","LU2129689431.USD","BK4007","LU1201861249.SGD","BAC","PFE","LU1496350171.SGD","LU1668664300.SGD","LU0289739699.SGD","BK4551","BK4539","LU0154236417.USD","BK4504","BK4588","NVOX","LU0234572021.USD","LU1363072403.SGD","BK4568","SG9999013999.USD","LU0321505868.SGD","PATX","NVOH","LU2265009873.SGD","LU0314106906.USD"],"gpt_icon":1}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction